Background illustration for clinical trials search

Paid Clinical Trials New Braunfels

Discover 1,413 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,413

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

for

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Location: New Braunfels TX, Houston TX, Abilene TX, Tyler TX,

Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06801834

Phase3, Recruiting

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

for

Small Cell Lung Cancer (SCLC)

Location: New Braunfels TX, San Antonio TX, Fredericksburg TX,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07226999

Phase2, Phase3, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for

Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,

Location: New Braunfels TX, San Antonio TX, Fredericksburg TX,

Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase3, Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for

Neovascular Age-related Macular Degeneration, nAMD

Location: Schertz TX, San Antonio TX, Austin TX, Houston TX,

Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase3, Recruiting

New

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

for

Type 2 Diabetes, Cardiovascular Risk

Location: San Antonio TX, Katy TX, Houston TX, Sugar Land TX,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 45+

Code: NCT07797335

Phase3, Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

for

Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,

Location: San Marcos TX, San Antonio TX, Houston TX, Mansfield TX,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07415044

Phase2, Recruiting

Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation

for

Motion Sickness

Location: San Antonio TX

Sponsor: 59th Medical Wing

Sex: All

Age: 18 - 50

Code: NCT06892340

Recruiting

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

for

Neovascular Age-Related Macular Degeneration (NVAMD),

Location: San Marcos TX, San Antonio TX, Austin TX, Round Rock TX,

Sponsor: EyeBiotech Ltd.

Sex: All

Age: 18+

Code: NCT07205887

Phase2, Recruiting

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

for

Tophaceous Gout

Location: San Marcos TX, San Antonio TX, Katy TX,

Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089888

Phase3, Recruiting

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

for

Alzheimer Disease, Dementia, Sleep Disorder, Sleep Disturbance

Location: San Marcos TX, Lakewood CO, Murfreesboro TN

Sponsor: University of Alabama, Tuscaloosa

Sex: All

Age: 50+

Code: NCT05820919

Recruiting

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

for

Active Rheumatoid Arthritis

Location: Jackson TX, Lake Charles LA, Baytown TX, Tomball TX,

Sponsor: Elevara Medicines Limited

Sex: All

Age: 18 - 70+

Code: NCT07409103

Phase2, Recruiting

A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair

for

Peripheral Nerve Injuries

Location: San Antonio TX, Houston TX, Columbus OH, San Diego CA,

Sponsor: Auxilium Biotechnologies

Sex: All

Age: 18 - 70+

Code: NCT06529835

Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for

Geographic Atrophy Secondary to Age-related Macular Degeneration,

Location: San Marcos TX, Schertz TX, San Antonio TX, Austin TX,

Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

for

Neoplasms, Head and Neck

Location: San Antonio TX, Fort Worth TX, Dallas TX, Tulsa OK,

Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06256588

Phase3, Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

for

Uterine Fibroids, Endometriosis

Location: San Antonio TX, Sugar Land TX, Houston TX, Pearland TX,

Sponsor: Sumitomo Pharma Switzerland GmbH

Sex: Female

Age: 18 - 50

Code: NCT05862272

Phase3, Recruiting

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

for

Failed or Difficult Intubation, Sequela, Intubation; Difficult,

Location: San Antonio TX, Austin TX, Irving TX, Dallas TX,

Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT02493478

Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

for

Hidradenitis Suppurativa (HS)

Location: San Antonio TX, Bellaire TX, Webster TX, Dallas TX,

Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06855498

Phase3, Recruiting

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for

Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,

Location: San Antonio TX, El Paso TX, Nashville TN, Denver CO,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 70+

Code: NCT05868629

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for

Breast Cancer

Location: San Antonio TX, Austin TX, Waco TX, Corpus Christi TX,

Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Location: San Antonio TX, Austin TX, Fort Worth TX, Tyler TX,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

Paid Clinical Trials New Braunfels

Filter results

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Interested in new trials?

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)